The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Fri., May. 29, 8:06 AM

Slide #9. Intersect ENT, Inc. Secondary Offering

Company: Intersect ENT, Inc. (NASDAQ:XENT)
Date announced: 5/20/2015
Shares Offered: 3,000,000
Secondary Offering Details: Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for a proposed underwritten public offering of 3,000,000 shares of its common stock to be sold by the company. In addition, the company expects to grant the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock from the company. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Intersect ENT is a commercial stage drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions. Co. has developed a drug-eluting bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. Co.'s products, PROPEL and PROPEL mini, are for use in patients with chronic sinusitis. Inserted by a physician during ethmoid sinus surgery, the self-expanding implants are designed to conform to and hold open the surgically enlarged sinus while gradually releasing an anti-inflammatory steroid over a period of 30 days, before being fully absorbed into the body.
Open the XENT Page at The Online Investor »

Company Name:  Intersect ENT, Inc.
Sector:  Medical Instruments & Supplies
Number of ETFs Holding XENT:  13
Total Market Value Held by ETFs:  $3.56M
Total Market Capitalization:  $558.00M
% of Market Cap. Held by ETFs:  0.64%

Open the XENT Page at The Online Investor (in a new window) »

May 29, 2015    8:06 AM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
87th percentile
(ranked higher than approx. 87% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.